Patents by Inventor Sumit Madan

Sumit Madan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20160128962
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: May 12, 2016
    Inventors: Harish Kumar MADAN, Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Ravi KOCHHAR
  • ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20160081965
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with a reduced dose. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: March 24, 2016
    Inventors: Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Harish Kumar MADAN, Ravi KOCHHAR, Simon Santosh JENA, Rajesh RAO, Anuj Kumar FANDA, Romi Barat SINGH
  • STABLE ORAL PHARMACEUTICAL COMPOSITION OF SOLIFENACIN
    Publication number: 20150150814
    Abstract: The present invention relates to stable oral pharmaceutical compositions comprising solifenacin or a salt thereof prepared by a double compaction process, wherein the amorphous content of solifenacin or a salt thereof in the composition is not less than 80% by weight. It further relates to a method of treating or preventing overactive bladder syndrome by administering said pharmaceutical compositions.
    Type: Application
    Filed: December 1, 2014
    Publication date: June 4, 2015
    Inventors: Rajesh Srikrishan SHEAR, Girish MITTAL, Sumit MADAN, Satish Kumar JAIN, Romi Barat SINGH
  • MULTIPARTICULATE EXTENDED-RELEASE COMPOSITION OF MESALAMINE
    Publication number: 20140178468
    Abstract: The present invention relates to a multiparticulate extended-release pharmaceutical composition of mesalamine comprising a) an inert core, b) an active ingredient layer and one or more pharmaceutically acceptable excipients, c) an inner coating layer comprising a water-insoluble cellulose derivative, and d) an outer coating layer comprising an enteric polymer.
    Type: Application
    Filed: December 23, 2013
    Publication date: June 26, 2014
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Rajesh S. SHEAR, Abhishank SINGH, Girish MITTAL, Sumit MADAN, Vinod Kumar ARORA
  • Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
    Patent number: 8664265
    Abstract: The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: March 4, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Arno Appavoo Enose, Harish Kumar Madan, Sumit Madan, Anupam Trehan, Puneet Tyagi, Vinod Kumar Arora
  • STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS
    Publication number: 20120183607
    Abstract: The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.
    Type: Application
    Filed: July 14, 2011
    Publication date: July 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Arno Appavoo ENOSE, Harish Kumar MADAN, Sumit MADAN, Anupam TREHAN, Puneet TYAGI, Vinod Kumar ARORA
  • ORAL METAXALONE COMPOSITIONS
    Publication number: 20120093928
    Abstract: The present invention relates to a pharmaceutical composition comprising low-dose metaxalone and one or more pharmaceutically acceptable polymer, as well as methods of preparing them.
    Type: Application
    Filed: August 6, 2008
    Publication date: April 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Rajesh S. Shear, Venkateshwaran Rathinasabapathy, Sumit Madan, Vinod Kumar Arora
  • LEVETIRACETAM CONTROLLED RELEASE COMPOSITION
    Publication number: 20120003307
    Abstract: The present invention is concerned with controlled release compositions for oral administration comprising levetiracetam; and with processes of preparing such controlled release compositions.
    Type: Application
    Filed: November 26, 2008
    Publication date: January 5, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Namdev M. Kashid, Sunny Chopra, Sumit Madan, Vinod Arora
  • HIGH DOSE ORAL PHARMACEUTICAL COMPOSITIONS OF ARTEMETHER AND LUMEFANTRINE
    Publication number: 20090324715
    Abstract: The present invention relates to high dose oral pharmaceutical compositions of artemether and lumefantrine, and process for preparation thereof. The compositions comprise of artemether and lumefantrine comprising artemether in an amount of from about 40 mg to about 80 mg, lumefantrine in an amount of from about 240 mg to about 480 mg. The compositions are useful for treatment of uncomplicated infections with Plasmodium falciparum, including strains from multi-drug-resistant areas.
    Type: Application
    Filed: June 22, 2007
    Publication date: December 31, 2009
    Inventors: Sumit Madan, Vikas Batra, Arno Appavoo Enose, Vinod Arora
  • STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS
    Publication number: 20090042821
    Abstract: The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.
    Type: Application
    Filed: May 18, 2006
    Publication date: February 12, 2009
    Inventors: Arno Appavoo Enose, Harish Kumar Madan, Sumit Madan, Anupam Trehan, Puneet Tyagi, Vinod Kumar Arora
  • Pharmaceutical compositions containing abiguanide-glitazone combination
    Publication number: 20060141023
    Abstract: The present invention relates to an orally administered pharmaceutical composition that is a combination of two or more antidiabetic agents in which one of the antidiabetic agents is present in an extended release form and the other antidiabetic agent is present in an immediate release form.
    Type: Application
    Filed: November 13, 2003
    Publication date: June 29, 2006
    Inventors: Anupam Trehan, Sumit Madan, Vinod Arora, Rajiv Malik
  • Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
    Publication number: 20060002998
    Abstract: The present invention relates to orally administered pharmaceutical compositions that include a combination of antidiabetic agents wherein one agent is present in an extended release form and the other agent is present in an immediate release form. For example, in one embodiment the dosage form includes an extended release layer that includes a biguanide; and an immediate release layer that includes a sulfonylurea.
    Type: Application
    Filed: November 17, 2003
    Publication date: January 5, 2006
    Inventors: Anupam Trehan, Sumit Madan, Vinod Arora, Rajiv Malik
  • Sustained release and long residing ophthalmic formulation and the process of preparing the same
    Patent number: 6579519
    Abstract: The present invention relates to sustained release and long residing opthalmic formulation having thermosensitivity, mucoadhesiveness, hydro gel properties and small particle size. The said formulation comprises micelle solution of random block co-polymer having a hydrophobic component and a hydrophillic component of general formula —(X+Y+Z-)m, and at least one hydrophobic drug with the block co-polymer solution. The invention also provides a process of preparing said formulation.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: June 17, 2003
    Assignee: Registrar, University of Delhi
    Inventors: Amarnath Maitra, Ajay Kumar Gupta, Dipak Majumdar, Sumit Madan
  • Sustained release and long residing ophthalmic formulation and the process of preparing the same
    Publication number: 20020064513
    Abstract: The present invent relates to sustained release and long residing ophthalmic formulation having thermosensitivity, mucoadhesiveness, hydro gel properties and small particle size.
    Type: Application
    Filed: September 18, 2001
    Publication date: May 30, 2002
    Inventors: Amarnath Maitra, Ajay Kumar Gupta, Dipak Majumdar, Sumit Madan